Latest Strategic Capital Raising News

BMG Resources has completed a $2.5 million capital raise to fund major drilling campaigns at its Abercromby and Bullabulling West gold projects in Western Australia, positioning the company for potential resource expansion.

DevEx Resources has announced a $35 million capital raise to fund key uranium tenement acquisitions and an aggressive 2026 exploration campaign in the Northern Territory’s Alligator Rivers Uranium Province.

Polymetals Resources has raised $34.4 million through a share placement to boost exploration and production at its Endeavor Silver Zinc Mine, attracting strong institutional demand.

Biotron Limited has completed a $1 million placement to fund the development of its newly acquired Sedarex Limited assets, marking a strategic expansion of its antiviral portfolio.

Bindi Metals Limited has launched a fully underwritten non-renounceable entitlement offer of new listed options to existing shareholders, aiming to raise capital through a strategic funding move.

North Stawell Minerals has raised $500,000 through a strategic share placement to fund ongoing gold exploration projects in Victoria’s Stawell Mineralised Corridor, reinforcing its position for growth into late 2026.

Elementos Limited has issued 17.5 million shares at 28 cents each as part of a strategic placement, with further shares planned for January 2026, positioning itself to capitalize on growing tin demand.

BPM Minerals has raised A$3.5 million through a placement to fund expanded drilling and exploration at its high-grade Forelands Gold Project in Western Australia. The capital injection positions the company to rapidly advance its maiden resource definition efforts.

Elixir Energy has raised approximately AUD 16.6 million through a two-tranche placement led by Omega Oil & Gas, aiming to fast-track its Taroom Trough gas projects and advance toward commercial production.

Maggie Beer Holdings has announced a $2.28 million entitlement offer priced at a 10.3% discount to raise working capital, inviting eligible shareholders to participate in a 1-for-10 share issue.

Biotron Limited has launched a $1.5 million non-renounceable rights issue to fund its strategic acquisition of Sedarex Limited and support ongoing drug development programs. The capital raise follows shareholder approval and aims to diversify Biotron’s portfolio with a next-generation general anaesthetic.

Sunrise Energy Metals has raised A$46 million through a strategic placement to advance pre-construction at its flagship Syerston Scandium Project, positioning itself as a key player in the scandium market amid supply uncertainties.